罕见病公众认知现状分析:基于杭州市滨江区调研数据
Analysis of the Current State of Public Awareness of Rare Diseases: Based on Survey Data from Binjiang District, Hangzhou City
DOI: 10.12677/bp.2026.162005, PDF,    科研立项经费支持
作者: 汪 亮, 赵梓博, 张嘉颖:杭州医学院临床医学院,浙江 杭州;陶文曦:杭州医学院检验医学院与生物工程学院,浙江 杭州
关键词: 罕见病公众认知影响因素问卷调查Rare Diseases Public Awareness Influencing Factors Questionnaire Survey
摘要: 目的:调查杭州滨江区群众罕见病认知现状及影响因素,为优化科普策略提供依据。方法:随机抽样开展问卷调查(含基本信息与10项认知测试题),用SPSS 23.0统计分析,多元线性回归探析影响因素(P < 0.05为差异有统计学意义)。结果:回收有效问卷300份,样本呈年轻高知特征;认知整体偏低(均值约50%,40%正确率区间占比最高,80%以上高分段不足16%);认知随年龄递减、学历递增,医疗卫生从业者认知显著更高;年龄(26~35岁影响最著)、学历(硕士及以上影响最著)、是否为医护职业是独立影响因素。结论:滨江区群众罕见病认知整体不足,存显著人口学差异;新媒体未消核心医学信息不对称;需开发标准化评估工具,开展科普干预纵向研究,推动个体认知转化为社会保障合力。
Abstract: Objective: To investigate the current status of public awareness of rare diseases and its influencing factors in Binjiang District, Hangzhou, and to provide a basis for optimizing public education strategies. Methods: A questionnaire survey (including basic information and 10 awareness test questions) was conducted using random sampling. Data were analyzed using SPSS 23.0, and multivariate linear regression was used to explore influencing factors (P < 0.05 was considered statistically significant). Results: A total of 300 valid questionnaires were collected. The sample was characterized by a young, highly educated demographic; overall awareness was low (mean approximately 50%, with the 40% correct response range having the highest proportion, and less than 16% scoring 80% or higher). Awareness decreased with age and increased with educational attainment; healthcare professionals demonstrated significantly higher awareness; Age (with the strongest effect observed in the 26~35 age group), educational attainment (with the strongest effect observed among those with a master’s degree or higher), and whether the respondent was a healthcare professional were identified as independent influencing factors. Conclusion: Overall awareness of rare diseases among the public in Binjiang District is insufficient, with significant demographic disparities; new media has not eliminated core medical information asymmetry; there is a need to develop standardized assessment tools, conduct longitudinal studies on science communication interventions, and promote the transformation of individual awareness into a collective effort for social security.
文章引用:汪亮, 赵梓博, 陶文曦, 张嘉颖. 罕见病公众认知现状分析:基于杭州市滨江区调研数据[J]. 生物过程, 2026, 16(2): 37-43. https://doi.org/10.12677/bp.2026.162005

参考文献

[1] 马正, 高嘉敏, 赵艺皓, 等. 罕见病政策国际经验及对我国的启示[J]. 中国卫生政策研究, 2018, 11(11): 61-67.
[2] 中国药学会儿童药物专业委员会, 国家儿童医学中心复旦大学附属儿科医院, 中国药师协会罕见病用药工作委员会, 等. 中国儿童罕见病临床用药管理专家共识(2025版) [J]. 中国实用儿科杂志, 2026, 41(2): 95-103.
[3] 陈立铭, 贾蒙, 何正阳, 等. 罕见病群体现状研究及对策分析[J]. 医学与哲学(B), 2016, 37(11): 3-6.
[4] Zanello, G., Garrido-Estepa, M., Crespo, A., O'Connor, D., Nabbout, R., Waters, C., et al. (2023) Targeting Shared Molecular Etiologies to Accelerate Drug Development for Rare Diseases. EMBO Molecular Medicine, 15, e17159. [Google Scholar] [CrossRef] [PubMed]
[5] Baynam, G., Hartman, A.L., Letinturier, M.C.V., Bolz-Johnson, M., Carrion, P., Grady, A.C., et al. (2024) Global Health for Rare Diseases through Primary Care. The Lancet Global Health, 12, e1192-e1199. [Google Scholar] [CrossRef] [PubMed]
[6] 周辛波, 孙阳, 钟武. 关于中国罕见病治疗药物的发展建议[J]. 国际药学研究杂志, 2017, 44(2): 85-90+93-94.
[7] 王远玭, 胡晓敏, 弓孟春, 等. 罕见病诊断的相关技术及发展[J]. 科技导报, 2017, 35(16): 26-30.
[8] 何达, 顾一纯, 顾善清, 等. 我国商业医疗保险参与保障高值罕用药使用的现状[J]. 中国卫生资源, 2021, 24(6): 631-635.
[9] 常精华, 宋海, 丁若溪, 等. 中国临床医生罕见病认知度及影响因素分析: 基于唐山调研数据[J]. 中国公共卫生, 2021, 37(5): 883-886.
[10] 李林康, 陶雪怡. 我国罕见病诊疗与保障事业现状及展望[J]. 中国新药与临床杂志, 2023, 42(2): 65-70+60.
[11] 上海市罕见病防治基金会简介[J]. 临床儿科杂志, 2023, 41(11): 881.
[12] 邹明明, 赵明杰. 人道功利主义视域下罕见病防治伦理治理路径研究[J]. 医学与哲学, 2022, 43(24): 10-14.
[13] 袁妮, 周娜, 张海军, 等. 药品全生命周期视角下中国罕见病药物保障政策简析[J]. 中国新药杂志, 2021, 30(1): 1-5.